A detailed history of Executive Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Executive Wealth Management, LLC holds 25,605 shares of AMGN stock, worth $7.96 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
25,605
Previous 30,675 16.53%
Holding current value
$7.96 Million
Previous $8.84 Million 17.6%
% of portfolio
0.67%
Previous 0.87%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $1.36 Million - $1.65 Million
-5,070 Reduced 16.53%
25,605 $7.28 Million
Q4 2023

Jan 26, 2024

BUY
$255.7 - $288.46 $113,019 - $127,499
442 Added 1.46%
30,675 $8.84 Million
Q3 2023

Nov 07, 2023

BUY
$218.65 - $271.46 $158,739 - $197,079
726 Added 2.46%
30,233 $8.13 Million
Q2 2023

Aug 02, 2023

BUY
$214.27 - $253.37 $917,504 - $1.08 Million
4,282 Added 16.98%
29,507 $6.55 Million
Q1 2023

May 11, 2023

SELL
$225.79 - $275.2 $1.16 Million - $1.42 Million
-5,153 Reduced 16.96%
25,225 $6.1 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $5.65 Million - $7.18 Million
24,674 Added 432.57%
30,378 $7.98 Million
Q3 2022

Nov 10, 2022

SELL
$224.46 - $253.15 $4.4 Million - $4.96 Million
-19,586 Reduced 77.45%
5,704 $5.7 Million
Q2 2022

Jul 26, 2022

SELL
$230.71 - $256.74 $2.03 Million - $2.26 Million
-8,785 Reduced 25.78%
25,290 $6.15 Million
Q1 2022

Apr 13, 2022

BUY
$219.27 - $242.57 $865,677 - $957,666
3,948 Added 13.1%
34,075 $8.24 Million
Q4 2021

Feb 03, 2022

BUY
$198.88 - $227.6 $275,846 - $315,681
1,387 Added 4.83%
30,127 $6.78 Million
Q3 2021

Oct 27, 2021

BUY
$212.27 - $248.7 $59,223 - $69,387
279 Added 0.98%
28,740 $6.11 Million
Q2 2021

Jul 26, 2021

BUY
$233.58 - $259.14 $5.64 Million - $6.25 Million
24,125 Added 556.39%
28,461 $6.94 Million
Q1 2021

May 03, 2021

BUY
$221.91 - $258.6 $308,898 - $359,971
1,392 Added 47.28%
4,336 $1.08 Million
Q4 2020

Feb 04, 2021

BUY
$216.38 - $257.67 $97,154 - $115,693
449 Added 18.0%
2,944 $677,000
Q3 2020

Oct 23, 2020

BUY
$234.65 - $260.95 $60,305 - $67,064
257 Added 11.48%
2,495 $634,000
Q2 2020

Jul 27, 2020

SELL
$197.81 - $242.74 $280,692 - $344,448
-1,419 Reduced 38.8%
2,238 $527,000
Q1 2020

Apr 27, 2020

SELL
$182.24 - $241.7 $321,653 - $426,600
-1,765 Reduced 32.55%
3,657 $741,000
Q4 2019

Jan 23, 2020

BUY
$189.21 - $243.2 $1.03 Million - $1.32 Million
5,422 New
5,422 $1.31 Million
Q3 2019

Oct 30, 2019

SELL
$174.11 - $208.62 $1.19 Million - $1.42 Million
-6,815 Closed
0 $0
Q2 2019

Aug 01, 2019

BUY
$166.7 - $195.41 $125,691 - $147,339
754 Added 12.44%
6,815 $1.26 Million
Q1 2019

May 02, 2019

SELL
$180.87 - $203.88 $125,342 - $141,288
-693 Reduced 10.26%
6,061 $1.15 Million
Q4 2018

Feb 19, 2019

BUY
$178.4 - $208.25 $1.2 Million - $1.41 Million
6,754 New
6,754 $1.32 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Executive Wealth Management, LLC Portfolio

Follow Executive Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Executive Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Executive Wealth Management, LLC with notifications on news.